Flow cytometric detection of Pig‐A mutant red blood cells using an erythroid‐specific antibody: Application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats
- 5 August 2009
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 51 (2) , 138-145
Abstract
A modified flow cytometry assay for Pig-A mutant rat red blood cells (RBCs) was developed using an antibody that positively identifies rat RBCs (monoclonal antibody HIS49). The assay was used in conjunction with a flow cytometric micronucleus (MN) assay to evaluate gene mutation and clastogenicity/aneugenicity in adolescent male and female rats treated with methylphenidate hydrochloride (MPH). Sprague-Dawley rats were treated orally with 3 mg/kg MPH (70/sex) or water (40/sex) 3 × /day on postnatal days (PNDs) 29–50. Eight additional rats (4/sex) were injected i.p. with N-ethyl-N-nitrosourea (ENU) on PND 28. Blood was collected on PNDs 29, 50, and 90, and used for determining serum MPH levels and/or conducting genotoxicity assays. On the first and last days of MPH treatment (PNDs 29 and 50), serum MPH levels averaged 21 pg/μl, well within the clinical treatment range. Relative to our previously published method (Miura et al. [2008]; Environ Mol Mutagen 49: 614–629), the HIS49 Pig-A mutation assay significantly reduced the background RBC mutant frequency; in the experiments with ENU-treated rats, the modification increased the overall sensitivity of the assay 2–3 fold. Even with the increased assay sensitivity, the 21 consecutive days of MPH treatment produced no evidence of Pig-A mutation induction (measured at PND 90); in addition, MPH treatment did not increase MN frequency (measured at PND 50). These results support the consensus view that the genotoxicity of MPH in pediatric patients reported earlier (El-Zein et al. [2005]: Cancer Lett 230: 284–291) cannot be reproduced in animal models, suggesting that MPH at clinically relevant levels may be nongenotoxic in humans. Environ. Mol. Mutagen. 2010. Published 2009 by Wiley-Liss, Inc.Keywords
This publication has 19 references indexed in Scilit:
- Methylphenidate and Amphetamine Do Not Induce Cytogenetic Damage in Lymphocytes of Children With ADHDJournal of the American Academy of Child & Adolescent Psychiatry, 2008
- Development of an in vivo gene mutation assay using the endogenous Pig‐A gene: I. Flow cytometric detection of CD59‐negative peripheral red blood cells and CD48‐negative spleen T‐cells from the ratEnvironmental and Molecular Mutagenesis, 2008
- Pharmacokinetics, dose‐range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 miceEnvironmental and Molecular Mutagenesis, 2008
- In vivo mutation assay based on the endogenous Pig‐a locusEnvironmental and Molecular Mutagenesis, 2008
- Does Methylphenidate Cause a Cytogenetic Effect in Children with Attention Deficit Hyperactivity Disorder?Environmental Health Perspectives, 2007
- Methylphenidate Blood Levels and Therapeutic Response in Children with Attention-Deficit Hyperactivity Disorder I. Effects of Different Dosing RegimensJournal of Child and Adolescent Psychopharmacology, 2006
- PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesisLeukemia & Lymphoma, 2006
- Cytogenetic effects in children treated with methylphenidateCancer Letters, 2005
- Toxicokinetic assessment of methylphenidate (Ritalin®) in a 13‐week oral (gavage) toxicity study in rats using an enantiomeric liquid chromatography/tandem mass spectrometry assayRapid Communications in Mass Spectrometry, 2003
- Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influenceNeuroscience & Biobehavioral Reviews, 2003